DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024
DURECT Corporation to present data on larsucosterol for alcohol-associated hepatitis at The Liver Meeting 2024, Nov 15-19 in San Diego, including Phase 2b trial results supporting Phase 3 trial design.
© Copyright 2024. All Rights Reserved by MedPath